Verzistobart Human Monoclonal Antibody
Verzistobartis a research-grade recombinant antibody targeting CD366. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
T-cell immunoglobulin mucin receptor 3, HAVcr-2, TIMD-3, T-cell membrane protein 3, HAVCR2, Hepatitis A virus cellular receptor 2, CD366, TIMD3, TIM-3, TIM3, T-cell immunoglobulin and mucin domain-containing protein 3
UniProt
Q8TDQ0
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1-kappa
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
031524-ML405 100 µL
ACBD6, NT (ACBD6, Acyl-CoA-binding domain-containing protein 6) (MaxLight 405) discontinued
Sign In for Pricing
View Details 
MBS142751-01 0.001 mg
Recombinant Protein Kinase A Inactive holoenzyme type 2 alpha
Sign In for Pricing
View Details MBS142751-02 0.003 mg
Recombinant Protein Kinase A Inactive holoenzyme type 2 alpha
Sign In for Pricing
View Details MBS142751-03 0.1 mg
Recombinant Protein Kinase A Inactive holoenzyme type 2 alpha
Sign In for Pricing
View Details MBS142751-04 5x 0.1 mg
Recombinant Protein Kinase A Inactive holoenzyme type 2 alpha
Sign In for Pricing
View Details